-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Reiterates Market Outperform on Mirum Pharmaceuticals, Maintains $137 Price Target

Benzinga·08/27/2026 14:01:27
Listen to the news
Citizens analyst Jonathan Wolleben reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Market Outperform and maintains $137 price target.